Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Corbus Pharmaceuticals Holdings, Inc.

NASDAQ: CRBP · Life Sciences · 6 alerts · CIK 1595097

Share price
$3.38Close, Nov 16
Market cap
$69.5M
Shares outstanding
20.61MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Corbus Pharmaceuticals Holdings, Inc. filings on SEC EDGAR ↗

10:28 AM ET 8-K
Investor Presentation

Corbus Pharmaceuticals Holdings Investor Presentation

Corbus Pharmaceuticals updated its corporate investor presentation to highlight its clinical pipeline in oncology and obesity. Key focus areas include the CRB-701 Nectin-4 ADC, which is entering a registrational Phase 2 study for OPSCC, and CRB-913, a CB1 inverse agonist for obesity with a Phase 2 study expected to start in the first half of 2027.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.